Global investment firm KKR buys Danish biotech firm share for USD 100m
Nordic Bioscience's owner group has sold a minority stake in the company to global investment company KKR for USD 100m.
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN
For the first time, the owners of Nordic Bioscience have opted to sell out of the biotech company. US investment company KKR has acquired a minority share in the Danish company, according to a KKR and Nordic Bioscience press announcement in which they mention neither the size nor the proportional share of the invested sum.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
